Back

Biodegradable polymer everolimus-eluting stents versus durable polymer everolimus-eluting stents in diabetic patients : a 3-year propensity-matched study

31 August 2019 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster Session 3 - Percutaneous coronary syndrome: pharma and devices Stents ESC Premium Access ESC Congress 2019

About the speaker

Photo
Doctor Hiroaki Matsuda

Nagoya Heart Center, Nagoya (Japan)

26 More presentations in this session

Presentation thumbnail
Real-world reasons and outcomes for 1-month versus longer dual antiplatelet therapy strategies with a polymer-free biolimus A9-coated stent: insights from the all-comers FREEDOM registry
Doctor G. Gallone (Turin, IT)
Abstract Slides
Presentation thumbnail
Long term clinical outcome of a novel sirolimus-eluting coronary stent in patients with acute myocardial infarction
Doctor S. Dani (Ahmedabad, IN)
Presentation thumbnail
Clinical outcomes of an ultra-thin strut sirolimus-eluting stent with biodegradable polymer in all-comers patients undergoing coronary intervention
Doctor I. Menown (Craigavon, GB)
Abstract
Presentation thumbnail
Final 5-year outcomes of the TRIAS High Risk of Restenosis; a multi-centre, randomized trial comparing endothelial progenitor cell capturing stent with drug-eluting stents
Miss L. Kerkmeijer (Zwolle, NL)
Abstract Slides
Presentation thumbnail
Long-term outcomes after percutaneous coronary intervention with biodegradable polymer drug-eluting stent versus second-generation durable polymer drug-eluting stent: evidence from a meta-analysis
Professor K. Cha (Pusan, KR)
Abstract

Access the full session

Session thumbnail
Poster Session 3 - Percutaneous coronary syndrome: pharma and devices

The Event

Event poster

ESC Congress 2019

31 August - 4 September 2019
You may be interested in
thumbnail
Congress Presentation
Percutaneous intervention is better than surgery in real life for most patients: pro
thumbnail
Congress Session
Complex PCI in practice: tips and tricks to take home
thumbnail
Congress Session
PCI complications: the lyrics from my worst nightmares

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources